Have you been diagnosed with atopic dermatitis also known as eczema?
If so, you might qualify for a clinical study for a new investigational medication to treat chronic itch as well as other symptoms of atopic dermatitis (eczema).
Qualified participants will receive study-related care and study medication at no charge as well as receive reimbursement for time and participation.
Atopic dermatitis or eczema patients have difficulty with a variety of symptoms including itch and excessive scratching, lesions, scarring, infection, and sleep disruption.
Researchers in the United States are looking for up to 500 adults diagnosed with atopic dermatitis (eczema) who:
The study duration is generally less than 3 months with a screening phase lasting approximately a couple of weeks and about 8 weeks of evaluation after being randomized to drug or placebo.